Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA Takeaways

Rhea-AI Summary

Altimmune, a clinical-stage biopharmaceutical company listed on Nasdaq under the symbol ALT, will participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day on June 26, 2024. Company leaders, including CEO Vipin Garg, Ph.D., and Chief Scientific Officer Scott Roberts, Ph.D., will discuss insights from the American Diabetes Association's Scientific Sessions during a fireside chat at 9:30 a.m. EDT. The session will be webcast and accessible via the Events section of the Altimmune website.

GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Piper Sandler 2^nd Annual Virtual Obesity Investor Day, being held on June 26, 2024, to discuss key takeaways from the American Diabetes Association’s (ADA) Scientific Sessions. Details on the fireside chat are as follows:

Title:	Piper Sandler Virtual Obesity Investor Day
Presenters:	Vipin Garg, Ph.D., Chief Executive Officer Scott Roberts, Ph.D., Chief Scientific Officer
Date/Time:	Wednesday, June 26, 2024 at 9:30 a.m. EDT

The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com

Investor Contacts:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com

Media Contact:
Danielle Cantey
Inizio Evoke Comms
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

FAQ

What event will Altimmune participate in on June 26, 2024?

Altimmune will participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day.

Who are the presenters from Altimmune at the Piper Sandler Virtual Obesity Investor Day?

The presenters from Altimmune are CEO Vipin Garg, Ph.D., and Chief Scientific Officer Scott Roberts, Ph.D.

What will Altimmune discuss at the Piper Sandler Virtual Obesity Investor Day?

Altimmune will discuss key takeaways from the American Diabetes Association's Scientific Sessions.

How can I watch Altimmune's session at the Piper Sandler Virtual Obesity Investor Day?

The session will be webcast and can be accessed via the Events section of the Altimmune website.

At what time will Altimmune's session at the Piper Sandler Virtual Obesity Investor Day take place?

Altimmune's session will take place at 9:30 a.m. EDT on June 26, 2024.